Cardiac Surgery
PROXICOR®
EXTRACELLULAR MATRIX FOR PERICARDIAL CLOSURE AND CARDIAC TISSUE REPAIR
Established in 2015, Aziyo Biologics is a commercially-oriented biotech company focused on regenerative medicine in areas such as cardiology, orthopedics and wound care. Since its founding, the Company has expanded through a combination of acquisitions and strategic partnerships, creating a high-growth commercial entity. Aziyo Biologic’s mission is to advance regenerative medicine platforms to dramatically improve patient outcomes.
In Cardiolink Group, we are the partners in Spain for the distribution of the following Aziyo Biologics’s products:
For updated information on these products, please refer to www.aziyo.com.
0344
